Absolute bioavailability of [14C] genistein in the rat; plasma pharmacokinetics of parent compound, genistein glucuronide and total radioactivity.
about
Phytochemicals for the Management of MelanomaBioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.Effects of estrogen and estrus cycle on pharmacokinetics, absorption, and disposition of genistein in female Sprague-Dawley rats.Absolute bioavailability of isoflavones from soy protein isolate-containing food in female BALB/c miceThe metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems.Method of variability optimization in pharmacokinetic data analysis.Preparation of Spray-Dried Soy Isoflavone-Loaded Gelatin Microspheres for Enhancement of Dissolution: Formulation, Characterization and in Vitro Evaluation.Mitigation of radiation-induced lung injury by genistein and EUK-207.Mitigation of lung injury after accidental exposure to radiation.Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice.Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.A genistein-enriched diet neither improves skeletal muscle oxidative capacity nor prevents the transition towards advanced insulin resistance in ZDF rats.Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats.Genistein-induced fluid accumulation in ovariectomised rats' uteri is associated with increased cystic fibrosis transmembrane regulator expression.Gender-dependent differences in uridine 5'-diphospho-glucuronosyltransferase have implications in metabolism and clearance of xenobiotics.Phenolic compounds: their journey after intake.Physiologically-based pharmacokinetic modeling of genistein in rats, Part I: Model development.Plasma bioavailability and changes in PBMC gene expression after treatment of ovariectomized rats with a commercial soy supplement.Effect of glycosidation of isoflavones on their bioavailability and pharmacokinetics in aged male rats.Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers.Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities.Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model.Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavonesBioavailability of soy isoflavones in rats Part I: application of accurate methodology for studying the effects of gender and source of isoflavones.A Combination of Intravenous Genistein Plus Mg2+ Enhances Antihypertensive Effects in SHR by Endothelial Protection and BKCa Channel Inhibition.
P2860
Q26766708-3DE0E059-9399-4502-AF70-4BD3E5CFC25BQ33567159-3EA96F5B-87C3-4EFD-B6C8-0E91C775789AQ33649023-0932DEA9-DA5F-4E50-B73C-1D3B4BAF1D31Q33889203-21D11360-6803-46B8-B500-34EDEC2B875FQ34005314-39F233A4-5534-4105-BDE3-224EFB9AE102Q34777859-A74E4007-73DF-45FD-9DFB-7E92D59001E0Q34785682-7185429A-239A-4F0F-9CC3-263FD66EA12BQ35163489-4828AF04-E37E-4FED-9AED-26D667D943B3Q35657493-BD91376B-AEFD-44E2-B4EF-592994F420B3Q36096060-A7878F3F-60DE-4668-876E-13F52AF89D97Q36296183-E8051EAA-4C88-4A02-B3BD-5713A172A8EEQ36681530-D6DDE5FE-6D94-4768-A3D8-B2795AA2AD2DQ37385369-4F8B73A5-CCBB-44BF-A863-A6204080B811Q37549925-30A54442-816D-4E3B-A096-9009D87CC64AQ38134859-A0355924-DB59-4728-AE02-E479FC0D72A2Q38171254-571E7F93-7A48-4A68-ADFF-8606F0BC1A01Q40338147-286A6336-CEFB-4240-9FF7-4385A896DD17Q41680668-DA177502-537F-4B86-A264-5EFBAE481BDCQ42168149-31EE8ADE-C60B-4C27-93CB-3545413C5F3AQ42659011-F30A9E23-826E-4F62-878D-D28FF3EB34E4Q43125236-57B351E9-7950-4C26-BB15-CFF1FEF469C8Q45083816-1EC17739-F1E2-45C7-B635-9569B3C9214FQ47157326-649AAF4A-29B3-4E2D-A058-15A2AF673D76Q51749850-0D34DB5F-5474-4BA8-BC03-11646CC66D0CQ53597491-3841FB4D-5538-4C74-A4B6-1FAFF679F210
P2860
Absolute bioavailability of [14C] genistein in the rat; plasma pharmacokinetics of parent compound, genistein glucuronide and total radioactivity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Absolute bioavailability of [1 ...... onide and total radioactivity.
@en
Absolute bioavailability of [1 ...... onide and total radioactivity.
@nl
type
label
Absolute bioavailability of [1 ...... onide and total radioactivity.
@en
Absolute bioavailability of [1 ...... onide and total radioactivity.
@nl
prefLabel
Absolute bioavailability of [1 ...... onide and total radioactivity.
@en
Absolute bioavailability of [1 ...... onide and total radioactivity.
@nl
P2093
P2860
P356
P1476
Absolute bioavailability of [1 ...... onide and total radioactivity.
@en
P2093
Ai-Qin Zhang
Maurice J Sauer
Nick G Coldham
Pauline Key
P2860
P2888
P304
P356
10.1007/BF03192335
P577
2002-10-01T00:00:00Z